| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |